Core Viewpoint - Goldman Sachs predicts that the Chinese stock market will enter a more sustained upward phase, with the MSCI China Index expected to rise approximately 30% by the end of 2027, driven by corporate earnings growth and valuation recovery [1][2]. Market Trends - The A-share market has recently experienced a style shift, with the ChiNext Index and STAR 50 Index undergoing significant pullbacks, while the CSI 300 Index and Dividend Index have remained strong [5]. - Despite recent market adjustments, the overall leverage level in the A-share market is considered manageable, with no signs of overheating, and the mid-term outlook remains positive [5]. Investment Strategy - Investors are advised to shift their mindset from "selling on highs" to "buying on lows," focusing on growth stocks, particularly leading private enterprises, AI-related companies, and firms benefiting from the "anti-involution" policy [3][4]. - Goldman Sachs emphasizes a strategy centered on excess returns, recommending investments in themes such as "China's top private enterprises," AI, and shareholder returns [3]. Factors Supporting Market Growth - Four key factors are identified as supporting a more durable rally in the Chinese stock market: the opening of favorable policy windows, accelerated corporate earnings growth driven by AI and "anti-involution" policies, relatively low current market valuations, and strong capital inflows into the stock market [2][3]. - The MSCI China Index has rebounded 80% from its cycle low at the end of 2022, despite experiencing four significant pullbacks during this period [2]. International Perspective - UBS continues to favor Chinese stocks over Indian stocks in emerging markets, citing faster revenue and earnings growth for Chinese companies, even excluding AI and internet stocks [4]. - Chinese technology stocks are gaining attractiveness due to their strong fundamentals, competitive cost structures, and robust management teams, despite some stocks still being undervalued [6].
高盛、瑞银 看多中国资产